000 01397 a2200373 4500
005 20250512033312.0
264 0 _c19890411
008 198904s 0 0 eng d
022 _a0035-9203
024 7 _a10.1016/0035-9203(88)90133-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWatkins, W M
245 0 0 _aChlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study.
_h[electronic resource]
260 _bTransactions of the Royal Society of Tropical Medicine and Hygiene
_c1988
300 _a398-403 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDapsone
_xtherapeutic use
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aKenya
650 0 4 _aMalaria
_xdrug therapy
650 0 4 _aPilot Projects
650 0 4 _aPlasmodium falciparum
650 0 4 _aProguanil
_xanalogs & derivatives
700 1 _aBrandling-Bennett, A D
700 1 _aNevill, C G
700 1 _aCarter, J Y
700 1 _aBoriga, D A
700 1 _aHowells, R E
700 1 _aKoech, D K
773 0 _tTransactions of the Royal Society of Tropical Medicine and Hygiene
_gvol. 82
_gno. 3
_gp. 398-403
856 4 0 _uhttps://doi.org/10.1016/0035-9203(88)90133-2
_zAvailable from publisher's website
999 _c3074666
_d3074666